Patent Pending
Current methods for treating nervous system disorders often rely on generalized approaches that may not optimally address the individual patient's specific pathology, leading to suboptimal outcomes. This innovation, developed by UC Berkeley researchers, provides a method to identify the most critical, or "influential," nodes within a patient's functional connectivity network derived from time-series data of an organ or organ system. The method involves obtaining multiple time-series datasets from an affected organ/system, using them to map the functional connectivity network, and then determining the most influential nodes within that network. By providing this specific and personalized information to a healthcare provider, a treatment can be prescribed that precisely targets the respective organ corresponding to these influential nodes. This personalized, data-driven approach offers a significant advantage over conventional treatments by focusing intervention on the most impactful biological targets, potentially leading to more effective and efficient patient care.
To guide personalized therapeutic interventions for patients suffering from various nervous system-related disorders. To assist healthcare providers in identifying the most effective treatment targets within a patient’s specific pathology. As a prognostic tool to predict treatment response based on the identified influential nodes. To non-invasively map and analyze functional connectivity networks in patients with neurological conditions.
Offers a personalized and targeted approach to treatment, moving beyond generalized protocols. Identifies the most influential nodes (critical targets) in the patient's functional connectivity network. Leverages time-series data to provide a dynamic, specific view of the patient's condition. Leads to more effective and efficient treatment prescriptions compared to existing methods. Provides actionable, data-driven insights to the healthcare provider.